⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Cognitive & Anxiolytic Peptide

SELANK

$29.99

TP-7

Selanc

Thr-Lys-Pro-Arg-Pro-Gly-Pro

CAS: 129954-34-3

A 7-amino acid synthetic heptapeptide derived from tuftsin that modulates GABAergic neurotransmission and BDNF expression, studied for anxiolytic and nootropic effects in clinical research. Premium Research Peptide.

Dosage
Quantity
1
$0.00
CoA

100% Secure payment

Free shipment protection

Overnight shipping available

Certificate of Analysis

Third Party Tested by Freedem Diagnostics

LATEST

PURITY

Variant

Lot #

Labeled

Actual

Tested

LATEST

PURITY

Variant

Lot #

Labeled

Actual

Tested

Quality you can Verify not just trust

Every batch is independently tested by accredited U.S. laboratories. We don't ask you to take our word for it—we give you the proof.

Verified Potency

Every vial is tested to confirm it contains exactly what the label says—down to the microgram.

99%+ Purity Guaranteed

Comprehensive testing confirms our peptides are free from impurities, degradation products, and synthesis byproducts.

Long-Term Stability

Optimal pH and formulation testing ensures your peptides remain effective throughout their entire shelf life.

Contaminant-Free

Rigorous sterility and endotoxin testing confirms products are free from bacteria, fungi, and harmful toxins.

Batch-to-Batch Consistency

Precision weighing and quality controls ensure every batch meets the same exacting standards.

99%+ Purity

Compound Information

Technical Specifications

Molecular Profile

What Is

SELANK

?

Synthetic heptapeptide analog of tuftsin, an immunomodulatory tetrapeptide derived from IgG

Heptapeptide

Tuftsin Analog

Type

Synthetic heptapeptide

CAS Number

129954-34-3

Molecular Formula

C33H57N11O9

Molecular Weight

751.9 g/mol

Amino Acids

7 residues

Sequence

Thr-Lys-Pro-Arg-Pro-Gly-Pro

STORAGE REQUIREMENTS

Stability Information

Handle with care to maintain potency

Light sensitive

Temperature sensitive

Lyophilized (powder)

-20°C • protect from light

Reconstituted

2-8°C • use within 4 weeks

Nasal spray (0.15%)

2-8°C • 30 days after opening

Development Status

Regulatory Information

Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences

Developer

Russian Academy of Sciences

Collaborator

V.V. Zakusov Institute

Approval

Russia (2009), Ukraine

Indication

Generalized Anxiety Disorder

US Status

Not FDA-approved

Formulation

0.15% nasal drops (Rx in Russia)

Sources & References

Peer-reviewed Research

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia

2008 • PMID: 18454096
Zozulia AA, Neznamov GG, Siuniakov TS, et al.
View Source
Behavioural Neurology

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats

2017 • PMID: 28280289
Kasian A, Kolomin T, Andreeva L, et al.
View Source
Frontiers in Pharmacology

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission

2016 • PMID: 26924987
Volkova A, Shadrina M, Kolomin T, et al.
View Source
Bulletin of Experimental Biology and Medicine

Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats

2019 • PMID: 31625062
Kozlovskii II, Andreeva LA, Myasoedov NF
View Source
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders

2014 • PMID: 25176261
Medvedev VE, Tereshchenko ON, Israelian AIu, et al.
View Source
Bulletin of Experimental Biology and Medicine

The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity

2001 • PMID: 11550013
Zozulya AA, Kost NV, Yu Sokolov O, et al.
View Source
Bulletin of Experimental Biology and Medicine

The Influence of Selank on the Level of Cytokines Under Conditions of Experimental Immunodeficiency

2020 • PMID: 32621722
View Source
Pharmacokinetic Data

Selank Intranasal Bioavailability Studies

View Source

IMPORTANT RESEARCH NOTICE

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

0

⛉ Free shipment protection included.

Delivery Truck 4 Streamline Icon: https://streamlinehq.com
Add $100.00 for free shipping
Empty Cart Your Cart is Empty!

It looks like you haven't added any items to your cart yet.

Browse Products
Subtotal
Shipping & taxes calculated at checkout.
$0.00
Checkout Now

Researcher Verification

Peptide Stash sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

Not a researcher? Exit